Vivos Therapeutics Inc (VVOS) USD0.0001

Sell:$2.22Buy:$2.26$0.09 (4.21%)

Prices delayed by at least 15 minutes
Sell:$2.22
Buy:$2.26
Change:$0.09 (4.21%)
Prices delayed by at least 15 minutes
Sell:$2.22
Buy:$2.26
Change:$0.09 (4.21%)
Prices delayed by at least 15 minutes

Company Information

About this company

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.

Key people

R. Kirk Huntsman
Chairman of the Board, Chief Executive Officer, Co-Founder
Bradford K. Amman
Chief Financial Officer
Ralph E. Green
Independent Director
Anja B. Krammer
Independent Director
Mark F. Lindsay
Independent Director
Leonard J. Sokolow
Independent Director
Matthew Thompson
Independent Director
Click to see more

Key facts

  • EPIC
    VVOS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US92859E2072
  • Market cap
    $12.60m
  • Employees
    109
  • Shares in issue
    6.72m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.